Brazilian Journal of Anesthesiology
Brazilian Journal of Anesthesiology
Original Investigation

Effects of magnesium sulphate on the onset time of rocuronium at different doses - a randomized clinical trial

Efeitos do sulfato de magnésio no tempo de início do rocurônio em diferentes doses: um ensaio clínico randomizado

Carlos Eduardo David de Almeida; Lidia Raquel de Carvalho; Carla Vasconcelos Caspar Andrade; Paulo do Nascimento Jr; Guilherme Antonio Moreira de Barros; Norma Sueli Pinheiro Modolo

Downloads: 1
Views: 22


Background and aims
Rocuronium may provide excellent onset time, but high doses are required for effective action. Several strategies have managed to shorten rocuronium onset time, including the use of Magnesium Sulphate (MgSO4).

One hundred and eighty patients were randomized into six groups according to rocuronium dose received (0.3, 0.6 or 1.2 and the administration of saline or MgSO4 (60 Correlations between tissue perfusion and rocuronium onset time was determined by variations in perfusion index.

Median (quartiles) rocuronium onset times were 85.5 (74.0–92.0); 76.0 (52.0–87.0) and 50.0 (41.0–59.5) seconds for 0.3, 0.6 and 1.2 doses, respectively. MgSO4 decreased rocuronium onset at doses of 0.3 (60.0 [48.0–74.3] seconds) and 0.6 (44.0 [39.0–49.0] seconds) but not at 1.2 (38.0 [33.5–56.3] seconds) (p <  0.001). Perfusion index variations in groups that received MgSO4 were greater than in controls. A negative correlation between shorten onset and increased perfusion index was observed in rocuronium doses of 0.3 (r = -0.50; p < 0.001) and 0.6 (r = -0.424; p <  0.001), but not for 1.2 dose (r = -0.25; p = 0.07).

MgSO4 reduces rocuronium onset time at doses of 0.3 and 0.6 being that the latter has a similar effect when compared to the dose of 1.2, with or without the use of MgSO4.


Magnesium sulphate;  Neuromuscular blocking agents;  Rocuronium


Justificativa e objetivos: O rocurônio pode fornecer um excelente tempo de início, mas altas doses são necessárias para uma ação eficaz. Várias estratégias conseguiram encurtar o tempo de início do rocurônio, incluindo o uso de sulfato de magnésio (MgSO4). Métodos: Cento e oitenta pacientes foram randomizados em seis grupos de acordo com a dose recebida de rocurônio (0,3, 0,6 ou 1,2 e a administração de solução salina ou MgSO4 (60 As correlações entre a perfusão tecidual e o tempo de início do rocurônio foram determinadas por variações no índice de perfusão. Resultados: Os tempos médios (quartis) de início do rocurônio foram 85,5 (74,0- -92,0); 76,0 (52,0 -87,0) e 50,0 (41,0 - 59,5) segundos para doses de 0,3, 0,6 e 1,2, respectivamente. O MgSO4 diminuiu o início do rocurônio com doses de 0,3 (60,0 [48,0 --- 74,3] segundos) e 0,6 (44,0 [39,0 - 49,0] segundos), mas não com 1,2 (38,0 [33,5 - 56,3] segundos) (p <0,001). As variações do índice de perfusão nos grupos que receberam MgSO4 foram maiores do que nos controles. Uma correlação negativa entre início encurtado e índice de perfusão aumentado foi observada em doses de rocurônio de 0,3 (r = -0,50; p <0,001) e 0,6 (r = -0,424; p <0,001), mas não para a dose de 1,2 (r = -0,25; p = 0,07). Conclusão: O MgSO4 reduz o tempo de aparecimento do rocurônio nas doses de 0,3 e 0,6, sendo este último efeito semelhante quando comparado à dose de 1,2, com ou sem o uso de MgSO4.


Sulfato de magnésio; Agentes de bloqueio neuromuscular; Rocurônio


1 D.T. Tran, E.K. Newton, V.A. Mount, J.S. Lee, G.A. Wells, J.J. Perry Rocuronium versus succinylcholine for rapid sequence induction intubation Cochrane Database Syst Rev. (2015), Article CD002788

2 K.C. McCourt, L. Salmela, R.K. Mirakhur, et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia Anaesthesia., 53 (1998), pp. 867-871

3 C. Lee, R.L. Katz Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux! J Crit Care., 24 (2009), pp. 43-49

4 C. Baillard, F. Adnet, S.W. Borron, et al. Tracheal intubation in routine practice with and without muscular relaxation: an observational study Eur J Anaesthesiol., 22 (2005), pp. 672-677

5 G. Kovacs, J.A. Law, J. Ross, et al. Acute airway management in the emergency department by non-anesthesiologists Can J Anaesth., 51 (2004), pp. 174-180

6 T. Mencke, M. Echternach, S. Kleinschmidt, et al. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial Anesthesiology., 98 (2003), pp. 1049-1056

7 H. Kirkegaard-Nielsen, J.E. Caldwell, P.D. Berry Rapid tracheal intubation with rocuronium: a probability approach to determining dose Anesthesiology., 91 (1999), pp. 131-136

8 C. Czarnetzki, C. Lysakowski, N. Elia, M.R. Tramer Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study Acta Anaesthesiol Scand., 54 (2010), pp. 299-306

9 B. Kussman, G. Shorten, J. Uppington, M.E. Comunale Administration of magnesium sulphate before rocuronium: effects on speed of onset and duration of neuromuscular block Br J Anaesth., 79 (1997), pp. 122-124

10 P. Rotava, I.L. Cavalcanti, L. Barrucand, L.A. Vane, N. Vercosa Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trial Eur J Anaesthesiol., 30 (2013), pp. 599-604

11 M.H. Kim, A.Y. Oh, S.H. Han, J.H. Kim, J.W. Hwang, Y.T. Jeon The effect of magnesium sulphate on intubating condition for rapid-sequence intubation: a randomized controlled trial J Clin Anesth., 27 (2015), pp. 595-601

12 T. Fuchs-Buder, C. Claudius, L.T. Skovgaard, et al. The International Neuromuscular M. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision Acta Anaesthesiol Scand., 51 (2007), pp. 789-808

13 A. Krishnamohan, V. Siriwardana, J.J. Skowno Using a pulse oximeter to determine clinical depth of anesthesia-investigation of the utility of the perfusion index Paediatr Anaesth., 26 (2016), pp. 1106-1111

14 D.A. Krendel Hypermagnesemia and neuromuscular transmission Semin Neurol., 10 (1990), pp. 42-45

15 S. Herroeder, M.E. Schonherr, S.G. De Hert, M.W. Hollmann Magnesium-essentials for anesthesiologists Anesthesiology., 114 (2011), pp. 971-993

16 W.J. Fawcett, E.J. Haxby, D.A. Male Magnesium: physiology and pharmacology Br J Anaesth., 83 (1999), pp. 302-320

17 D. Zheng, R.N. Upton, G.L. Ludbrook, A. Martinez Acute cardiovascular effects of magnesium and their relationship to systemic and myocardial magnesium concentrations after short infusion in awake sheep J Pharmacol Exp Ther., 297 (2001), pp. 1176-1183

18 N.M. Elsharnouby, M.M. Elsharnouby Magnesium sulphate as a technique of hypotensive anaesthesia Br J Anaesth., 96 (2006), pp. 727-731

19 D.W. Han, D.H. Chun, T.D. Kweon, Y.S. Shin Significance of the injection timing of ephedrine to reduce the onset time of rocuronium Anaesthesia., 63 (2008), pp. 856-860

20 P. Szmuk, T. Ezri, J.E. Chelly, J. Katz The onset time of rocuronium is slowed by esmolol and accelerated by ephedrine Anesth Analg., 90 (2000), pp. 1217-1219

21 F. Donati, C. Meistelman A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs J Pharmacokinet Biopharm., 19 (1991), pp. 537-552

22 A.A. Dahaba, S.I. Perelman, D.M. Moskowitz, et al. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage Anesthesiology., 104 (2006), pp. 950-953

23 M. Adamus, L. Hrabalek, T. Wanek, T. Gabrhelik, J. Zapletalova Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intravenous anesthesia Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub., 155 (2011), pp. 347-353

24 C. Bergek, J.H. Zdolsek, R.G. Hahn Non-invasive blood haemoglobin and plethysmographic variability index during brachial plexus block Br J Anaesth., 114 (2015), pp. 812-817

25 S. Toyama, M. Kakumoto, M. Morioka, et al. Perfusion index derived from a pulse oximeter can predict the incidence of hypotension during spinal anaesthesia for Caesarean delivery Br J Anaesth., 111 (2013), pp. 235-241

26 A.G. Euser, M.J. Cipolla Magnesium sulfate for the treatment of eclampsia: a brief review Stroke., 40 (2009), pp. 1169-1175

27 R.W. Allen, M.F. James, P.C. Uys Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate Br J Anaesth., 66 (1991), pp. 216-223

28 Y. Aissaoui, Y. Qamous, I. Serghini, M. Zoubir, J.L. Salim, M. Boughalem Magnesium sulphate: an adjuvant to tracheal intubation without muscle relaxation--a randomised study Eur J Anaesthesiol., 29 (2012), pp. 391-397

29 T.M. Hemmerling, F. Donati Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review Can J Anaesth., 50 (2003), pp. 779-794

30 M. Mesbah Kiaee, S. Safari, G.R. Movaseghi, et al. The effect of intravenous magnesium sulfate and lidocaine in hemodynamic responses to endotracheal intubation in elective coronary artery bypass grafting: a randomized controlled clinical trial Anesth Pain Med., 4 (2014), Article e15905

31 P.A. Germano Filho, I.L. Cavalcanti, L. Barrucand, N. Vercosa Effect of magnesium sulphate on sugammadex reversal time for neuromuscular blockade: a randomised controlled study Anaesthesia., 70 (2015), pp. 956-961

611feff7a95395750a19ad63 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections